Max Robotics — Global Service Robot Directory + US Certification

About

Zu-Kai Wang is a leading surgical oncologist specializing in minimally invasive gastric cancer surgery, with a particular focus on robotic and laparoscopic techniques. His research centers on comparing the oncological safety and perioperative outcomes of robotic gastrectomy (RG) versus laparoscopic gastrectomy (LG), aiming to establish evidence-based guidelines for surgical decision-making. Wang’s most impactful work, a 2024 study comparing short-term and three-year oncological outcomes between RG and LG in 3,599 patients (23 citations), provides critical insights into the long-term efficacy of robotic approaches. He further demonstrated the advantages of robotic spleen-preserving total gastrectomy in a 2022 comparative study (13 citations), showing superior short-term outcomes. These contributions have helped clarify the clinical benefits of robotic surgery, including reduced blood loss and faster recovery, while confirming comparable oncological results. Wang’s research is instrumental in advancing minimally invasive gastric cancer treatment, offering surgeons and patients robust data to guide therapeutic choices. His work continues to shape the evolution of robotic surgical techniques in gastrointestinal oncology.